Brief: Appili Therapeutics Inc As Of September 30, 2022, Company Had Cash Of $2.4 Million, Compared To $6.7 Million On March 31, 2022

Appili Therapeutics

10/11/2022 12:58

Nov 10 (Reuters) - Appili Therapeutics Inc  APLI.TO :
    * APPILI THERAPEUTICS INC - FOR 6 MONTHS ENDED SEPT 30, 2022
LOSS
PER SHARE $0.04
    * APPILI THERAPEUTICS - PLANS TO FOCUS RESOURCES ON
ADVANCING
PORTFOLIO OF INFECTIOUS DISEASE, BIODEFENSE ASSETS, INCLUDING
ATI-1701, ATI-1801, ATI-1501
    * APPILI THERAPEUTICS - WILL DISCONTINUE DEVELOPMENT OF
REMAINING
PORTFOLIO PROGRAMS ATI-2307 AND ATI-1503
    * APPILI THERAPEUTICS REPORTS FINANCIAL AND OPERATIONAL
RESULTS
FOR SECOND QUARTER OF FISCAL YEAR 2023
    * APPILI THERAPEUTICS INC - AS OF SEPTEMBER 30, 2022,
COMPANY HAD
CASH OF $2.4 MILLION, COMPARED TO $6.7 MILLION ON MARCH 31, 2022

Further company coverage:  APLI.TO 
 ((Reuters.Briefs@thomsonreuters.com;))